Please login to the form below

Not currently logged in


This page shows the latest Vabysmo news and features for those working in and with pharma, biotech and healthcare.

Roche’s Vabysmo recommended for EU approval by CHMP for sight loss

Roche’s Vabysmo recommended for EU approval by CHMP for sight loss

The European Commission (EC) is expected to issue a final verdict on the approval of Vabysmo in the near future. ... By blocking pathways involving Ang-2 and VEGF-A, Vabysmo has been developed to stabilise blood vessels.

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation